Tyra Biosciences (NASDAQ: TYRA) CMO awarded RSUs and 85,000-share option
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tyra Biosciences, Inc. reported that Chief Medical Officer Douglas J. Warner received new equity awards as part of his compensation. He was granted 25,000 restricted stock units (RSUs), each representing one share of common stock, with one quarter vesting on each of the first four anniversaries of May 5, 2026, subject to his continuous service. He also received a stock option for 85,000 shares of common stock at an exercise price of $33.93 per share, vesting in equal monthly installments over 48 months following May 5, 2026, also conditioned on continued service. These are grants and not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Warner Douglas J
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 85,000 | $0.00 | -- |
| Grant/Award | Common Stock | 25,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 85,000 shares (Direct, null);
Common Stock — 25,000 shares (Direct, null)
Footnotes (1)
- Represents restricted stock units ("RSUs") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. Includes RSUs. 1/48th of the shares subject to the option vest monthly following May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Key Figures
RSU grant size: 25,000 RSUs
Option grant size: 85,000 options
Option exercise price: $33.93 per share
+3 more
6 metrics
RSU grant size
25,000 RSUs
Granted to CMO on May 5, 2026; vests over four years
Option grant size
85,000 options
Stock Option (Right to Buy) granted May 5, 2026
Option exercise price
$33.93 per share
Exercise price for 85,000-share stock option
RSUs after grant
25,000 shares
Total common shares underlying RSUs following transaction
Options after grant
85,000 options
Total stock options held following transaction
Option expiration
May 4, 2036
Expiration date of 85,000-share stock option
Key Terms
restricted stock units, RSUs, Stock Option (Right to Buy), vesting commencement date, +1 more
5 terms
restricted stock units financial
"Represents restricted stock units ("RSUs") granted on May 5, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of common stock"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
vesting commencement date financial
"the vesting commencement date, subject to the Reporting Person's continuous service"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each vesting date"
FAQ
What insider transaction did Tyra Biosciences (TYRA) report for Douglas J. Warner?
Tyra Biosciences reported that Chief Medical Officer Douglas J. Warner received equity grants. He was awarded 25,000 restricted stock units and a stock option for 85,000 shares, both granted on May 5, 2026, as part of his compensation package.
How many RSUs did the Tyra Biosciences (TYRA) CMO receive in this Form 4?
Douglas J. Warner received 25,000 restricted stock units. One quarter of these RSUs vest on each of the first four anniversaries of May 5, 2026, provided he remains in continuous service with Tyra Biosciences through each vesting date.
Are the Tyra Biosciences (TYRA) insider grants open-market purchases or compensation awards?
The transactions are compensation-related awards, not open-market trades. Both the 25,000 restricted stock units and the 85,000-share stock option were granted at no cash cost to Douglas J. Warner as part of his role as Chief Medical Officer.
When do Douglas J. Warner’s Tyra Biosciences (TYRA) RSUs and options start vesting?
Both awards use May 5, 2026 as the vesting commencement date. The RSUs vest annually over four years, while the stock option vests in equal monthly installments over 48 months, subject in each case to continuous service with Tyra Biosciences.